Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue
J A
JA
Beatson Oncology Centre, Belvidere Hospital, Glasgow.
Wheldon
T E
TE
Babich
J W
JW
Moyes
J S
JS
Barrett
A
A
Meller
S T
ST
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001692:Biological Transport; D002648:Child; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015233:Models, Statistical; D009447:Neuroblastoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D011336:Probability; D011379:Prognosis
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine